Incyte Gets FDA Approval For Breakthrough Therapy Status For Its Ruxolitinib
June 23, 2016 at 09:11 AM EDT
Incyte Corporation (NASDAQ: INCY) revealed Thursday that the Food and Drug Administration has granted Breakthrough Therapy Status for ...